Coagulation Studies Flashcards
What is microangiopathic hemolytic anemia?
Mechanical shearing (fragmentation) or RBCs as they pass through platelet rich microthrombi in microvasculature
What is heparin induced thrombocytopenia?
New onset thrombocytopenia/thrombus while on heparin therapy
Antiplatelet antibodies cause platelet activation- increased risk of thrombosis- lead to thrombocytopenia and prothrombotic states
Labs for warfarin
Baseline: PT/INR, aPTT, CBC, creatinine, LFTS, pregnancy test
Factors to determine anticoagulation therapy
Initial vs long term agent, route, renal function, antidote, contraindications (pregnancy or risk of hemorrhage grater than benefit), cost, duration, compliance etc
Labs needed for pt on LMWH
Baseline: aPTT, PT/INR, CBC, creatinine
Monitoring: none really, anti-factor Xa activity testing if required
Usually pt weight based
Reversal agents for direct thrombin inhibitors
Idarucizumab for Dabigatran but others is just supportive care for non-life threatening bleeding
What is another name for hemolytic uremia syndrome?
Shiga-toxin mediated HUS
Types of anticoagulants
UFH LMWH Warfarin (vitamin K agonist) Factor Xa inhibitors Oral direction thrombin inhibitors
Labs needed for a pt on UFH
Baseline: aPTT, PT/INR
Monitoring: aPTT or factor Xa
Primary hypercoagulable disorders
Antithrombin or protein c/s deficiencies, factor V leiden and prothrombin gene mutations
Target INR by condition: Prophylaxis VTE Afib Mitral mechanical valve Aortic mechanical valve
1.5-2 2-3 2-3 2.5-3.5 2-3 < means blood is too thick and more then it means risk of bleeding
Platelet disorders
Platelet dysfunction, splenic sequestration, increased destruction, impaired production
What does warfarin do?
Inhibits conversion of vitamin K to active form which depletes vitamin K dependent clotting factors and inhibits protein C (inhibits propagation but does not remove thrombus)
Reversal agent for UFH/LMWH
Protamine
What is thrombotic thrombocytopenic purpura?
Medical emergency
Seen in females and blacks
Either acquired (autoantibodies directed against ADAMTS-13 like in pregnancy) or inherited ADAMTS-13 mutations
Microthrombi are formed throughout the body
PPT or aPTT
Evaluates intrinsic and common pathways
Monitor UFH therapy
Monitoring for warfarin therapy
Titrate dose to appropriate INR
Monitor INR frequently (daily and then weekly then every 2-4 wks)
Fun fact: vitamin K will decrease INR
What is overlap therapy with warfarin?
Parental therapy (UFH/LMWH/fondaparinux) should overlap with warfarin for at least 5 days and until INR is therapeutic for minimum of 24 hrs or 2 days